Alekel DL, St Germain A, Peterson C, Hanson K, Stewart JW, Toda T: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women . Am J Clin Nutr 72:844–852, 2000.

Bahram H. Arjmandi: The Role of Phytoestrogens in the Prevention and Treatment of Osteoporosis in Ovarian Hormone Deficiency . Journal of the American College of Nutrition, Vol. 20, No. 5, 398S–402S (2001)

Bonnic SL: AMWA position statement on osteoporosis. J Am Med Women Assoc 45:75–79, 1990.

Brzezinski A, Debi A: Phytoestrogens: the “natural” selective estrogen receptor modulators. Eu J Obstet Gynecol Rep Biol 85:47–51, 1999.

Cosman F, Lindsay R : Selective estrogen receptor modulators: Clinical spectrum. Endocr Rev 20:418–434, 1999.

Dempster DW, Lindsay R: Pathogenesis of osteoporosis. Lancet 341:797–801, 1996.

Johannes CB, Crawford SL, Posner JG, McKinlay SM: Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women . Am J Epidemiol 140:439–452, 1994.

Mundy GR: Visions for the future in osteoporosis research. Osteoporos Int 2(Suppl): 29S–34S, 1993.

Tolstoi LG, Levin RM: Osteoporosis—the treatment controversy. Nutr Today 27:6–12, 1992.

Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer MS: Effects of soy isoflavones on markers of bone turnover in premenopausal and  postmenopausal women . J Clin Endocrinol Metab 85:3043–3048, 2000.